April 13, 2026
7-minute read

TAPI EHS&S Awards 2025: Celebrating the People Driving Safer, Smarter, More Sustainable Progress

At TAPI, advancing health from the core means more than scientific excellence. It also means protecting people, preserving resources, and building a safer, more sustainable future across our global organization.  That is the idea behind the first-ever TAPI EHS&S Awards 2025 — a new global initiative created to recognize exceptional contributions in Environment, Health, Safety and Sustainability across TAPI.  […]

Filter by:

Last Site Inspections

Feb 8, 2025

Teva API had a successful inspection in the Teva api Mexico site by Local MOH

Jan 15, 2025

Teva API had a successful inspection in the Teva api India, Gajraula site by Local MOH

Jan 4, 2025

Teva API had a successful inspection in the Teva api Croatia, Zagred site by Local MOH

Latest Catalog Updates

2026
Mavacamten
US DMF
2026
Ixazomib Citrate
US DMF
2026
Voclosporin
EU DMF
2026
Edoxaban Tosylate
CA DMF

Contact us

Step 1 of

    First name*
    Last name*
    Business email*
    Company*
    Job title*
    Country*
    I'm interested in*
    Segment of interest*
    Tell us more about your project
    Select product*
    Formulation
    Project type*
    Target market
    Quantity
    Comments
    Disclaimer: This material might be protected by exclusive rights such as patents and/or supplementary protection certificates or extensions in certain jurisdictions, and therefore might not be available for specific countries. TAPI will only be able to offer and supply this pharmaceutical ingredient in the countries and exclusively for uses that are exempt from infringement of such exclusive rights in accordance with applicable law. TAPI requires adequate confirmation of the exempt use upon ordering.
    By clicking submit, you are agreeing to our Privacy Policy